Open AccessRole of Combination Therapy with SGLT2 Inhibitor with Metformin as Initial Treatment for Type2 Diabetes-Advantages of Oral Fixed Drug Pill Like Empagliflozin/Metformin in Patients with Cardiovascular and Renal Risk-A Short Communication
Author(s) -
Kulvinder Kochar Kaur,
Gautam Allahbadia,
Mandeep Singh
Publication year - 2019
Publication title -
archives of diabetes and endocrine system
Language(s) - English
Resource type - Journals
ISSN - 2638-4981
DOI - 10.22259/2638-4981.0201002
Subject(s) - empagliflozin , metformin , medicine , pill , diabetes mellitus , type 2 diabetes , drug , pharmacology , endocrinology